🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Withdrawn
Location
Mayo Clinic Jacksonville ( Site 0003)
Start Date
2017-08-01
Trial ID
NCT03221634
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Status
Active Not Recruiting
Location
Transplant-nephrology department
Start Date
2025-11-01
Trial ID
NCT07274462
Treatments Being Tested
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested
To search for a Maximum Tolerated Dose (MTD) for the combination of daratum...
Status
Recruiting
Location
CHU de Nantes
Start Date
2025-02-06
Trial ID
NCT05749276
Treatments Being Tested
The goal of this clinical trial is to compare the pharmacokinetic and safet...
Status
Unknown
Location
The First Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2024-04-12
Trial ID
NCT06371534
Treatments Being Tested
The aim of this study is to confirm the comparability of the efficacy and s...
Status
Unknown
Location
Chelyabinsk Regional Clinical Hospital
Start Date
2023-12-21
Trial ID
NCT06296121
The objective of this non-interventional study (NIS) is to evaluate patient...
Status
Completed
Location
Centrum für Hämatologie und Onkologie Bethanien
Start Date
2016-10-25
Trial ID
NCT02970747
Treatments Being Tested